vimarsana.com
Home
Live Updates
Avacta Group plc: Avacta Opens First Two US Clinical Investi
Avacta Group plc: Avacta Opens First Two US Clinical Investi
Avacta Group plc: Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study
Memorial Sloan Kettering Cancer Center and Fred Hutch Cancer Center now open for patient enrolment to pre|CISION lead programme, AVA6000 Avacta Group plc (AIM: AVCT), a life sciences company developing
Related Keywords
New York ,
United States ,
United Kingdom ,
Memorial Sloan Kettering Cancer Center ,
Lily Jeffery ,
Leed Cranmer ,
Oneil Bell ,
Alastair Smith ,
Zyme Communications ,
Sarcoma Medical Oncology Service ,
Avacta Group ,
Fred Hutch Cancer Center ,
New Drug ,
Application The ,
Clinical Research Division ,
Fred Hutch Cancer ,
Chief Development Officer ,
Professor Cranmer ,
Chief Executive Officer ,
Avacta ,
Group ,
Pens ,
First ,
Linical ,
Investigator ,
Sites ,
Va6000 ,
Hase ,
Study ,